World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
11685
World Ranking
3348
National Ranking
131

Michèl R. Klein publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michèl R. Klein sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 116 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michèl R. Klein D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michèl R. Klein sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michèl R. Klein is affiliated with Leiden University Medical Center in the Netherlands. Their research is situated primarily within the field of Medicine, with a particular focus on Infectious Diseases, Epidemiology, and Surgery.

Their work centers around several related topics including Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Diagnosis and treatment of tuberculosis, and Infectious Diseases and Tuberculosis.

Klein has contributed to the following recent papers:

  • RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response (2020, Scientific Reports)
  • T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection (2023, Nature Medicine)

They have collaborated frequently with a core group of co-authors, including Nicole Bilek, Thomas J. Scriba, E. Jane Hughes, Ashley Veldsman, and Mzwandile Erasmus.

The main publication venues for Klein's work are Scientific Reports and Nature Medicine.

Best Publications

  • Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells

    Dörte Hamann;Paul A. Baars;Martin H.G. Rep;Berend Hooibrink

  • Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

    M R Klein;C A van Baalen;A M Holwerda;S R Kerkhof Garde

  • MASS ACCUMULATION RATES IN ASIA DURING THE CENOZOIC

    François Métivier;Yves Gaudemer;Paul Tapponnier;Michel Klein

  • Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.

    Eliane M.S. Leyten;May Young Lin;Kees L.M.C. Franken;Annemieke H. Friggen

  • Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers

    Jaap T. van Dissel;Sandra M. Arend;Corine Prins;Peter Bang

  • Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis

    Abebech Demissie;Eliane M. S. Leyten;Markos Abebe;Liya Wassie

  • Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS

    C.A. van Baalen;O. Pontesilli;R.C. Huisman;A.M. Geretti

  • High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.

    S Kostense;G S Ogg;E H Manting;G Gillespie

  • Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

    Simone A. Joosten;Krista E. van Meijgaarden;Nigel D. L. Savage;Tjitske de Boer

  • Immunogenicity of Eight Dormancy Regulon-Encoded Proteins of Mycobacterium tuberculosis in DNA-Vaccinated and Tuberculosis-Infected Mice

    Virginie Roupie;Marta Romano;Lei Zhang;Hannelie Korf

  • Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression

    Graham S. Ogg;Stefan Kostense;Michel R. Klein;Suzanne Jurriaans

  • Changing virus-host interactions in the course of HIV-1 infection.

    Frank Miedema;Linde Meyaard;Maarten Koot;Michel Klein

  • Protection against respiratory syncytial virus infection by DNA immunization.

    Xiaomao Li;Suryaprakash Sambhara;Cindy Xin Li;Mary Ewasyshyn

  • Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8+ T-cells with cytotoxic as well as regulatory activity.

    Simone A. Joosten;Krista E. van Meijgaarden;Pascale C. van Weeren;Fatima Kazi

  • Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

    Gillian F. Black;Bonnie A. Thiel;Martin O. Ota;Shreemanta K. Parida

  • Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.

    Norbert A. Foudraine;Egbert Hovenkamp;Daan W. Notermans;Pieter L. Meenhorst

  • Human CD8+ CTL Specific for the Mycobacterial Major Secreted Antigen 85A

    Steven M. Smith;Roger Brookes;Michèl R. Klein;Adam S. Malin

  • Review of enterovirus 71 vaccines

    Pele Chong;Chia-Chyi Liu;Yen-Hung Chow;Yen-Hung Chow;Ai-Hsiang Chou

  • Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region.

    Michel Klein;Nicole Haeffner-Cavaillon;David E. Isenman;Claude Rivat

  • Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.

    M. R. Klein;S. H. Van Der Burg;E. Hovenkamp;A. M. Holwerda

Frequent Co-Authors

Frank Miedema
Frank Miedema Utrecht University
Tom H. M. Ottenhoff
Tom H. M. Ottenhoff Leiden University Medical Center
Kees L. M. C. Franken
Kees L. M. C. Franken Leiden University Medical Center
Krista E. van Meijgaarden
Krista E. van Meijgaarden Leiden University Medical Center
F. de Wolf
F. de Wolf Imperial College London
Annemieke Geluk
Annemieke Geluk Leiden University Medical Center
Suryaprakash Sambhara
Suryaprakash Sambhara Centers for Disease Control and Prevention
Hazel M. Dockrell
Hazel M. Dockrell London School of Hygiene & Tropical Medicine
Anna Maria Geretti
Anna Maria Geretti University of Liverpool
Nicole Haeffner-Cavaillon
Nicole Haeffner-Cavaillon Inserm : Institut national de la santé et de la recherche médicale

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can broaden career opportunities. Many students choose to complement their scientific knowledge with nursing credentials, which open doors to clinical roles and patient care specialties. If you are considering a fast track to advanced nursing, exploring accelerated fnp programs offers a way to become a Family Nurse Practitioner more quickly and start practicing in diverse healthcare settings.

For individuals without a nursing background, enrolling in the best online bsn programs for non nurses provides an accessible pathway into the nursing profession. These programs are designed to build foundational clinical skills and merge well with immunology knowledge for roles in infection control and research.

If entry requirements or program duration are concerns, many students find success through easiest accelerated nursing programs, which are designed to accommodate varying academic backgrounds and expedite graduation. Similarly, for those seeking a quicker route to healthcare employment, accredited lpn programs easy to get into offer practical, entry-level nursing education with a focus on direct patient care.

Combining immunology with these nursing tracks can lead to impactful careers in clinical research, public health, and specialized nursing roles focused on immunotherapies and infectious diseases.

Best Scientists Citing Michèl R. Klein

Recently Published Articles